Increased expression of the interleukin-11 receptor and evidence of STAT3 activation in prostate carcinoma

American Journal of Pathology

Volumn 158, Issue 1, 2001, Pages 25-32

  Campbell, Cara L ^a   Jiang, Zhong ^a   Savarese, Diane M F ^b   Savarese, Todd M ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b University of Massachusetts   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 130; INTERLEUKIN 11 RECEPTOR; INTERLEUKIN 11 RECEPTOR ALPHA; INTERLEUKIN 6; RECOMBINANT INTERLEUKIN 11; STAT3 PROTEIN; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; CYTOKINE PRODUCTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION;

EID: 0035144809     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63940-5     Document Type: Article

References (42)

1. Cancer statistics, 1999
2. Molecular cloning of a cDNA encoding interleukin-11, a stromal cell-derived lymphopoietic and hematopoietic cytokine
3. Interleukin-11: Review of molecular, cell biology and clinical use
4. Interleukin-11 inhibits adipogenesis and stimulates myelopoiesis in human long-term marrow cultures
5. Interleukin-11: A new cytokine critical for osteoclast development
6. IL-11, a pleotrophic cytokine: Exciting new effects of IL-11 on gastrointestinal mucosal biology
7. Interleukin-11 protects the clonogenic stem cells in murine small intestinal crypts from impairment of their reproductive capacity by radiation
8. Interleukin-11 prevents apoptosis and accelerates recovery of small intestinal mucosa in mice treated with combined chemotherapy and radiation
9. Protective effects of interleukin-11 in a murine model of ischemic bowel necrosis
10. Interleukin-6 family of cytokines and gp130
11. Interleukin-6 type cytokine signaling through the gp130/Jak/STAT pathway
12. Activation of the signal transducer gp130 by interleukin-11 and interleukin-6 is mediated by similar molecular interactions
13. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6β receptor components
14. Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors
15. STATs and gene regulation
16. Tyrosine phosphorylation of JAK-TYK kinases in malignant plasma cell lines growth-stimulated by interleukins 6 and 11
17. Identification of a 130 kilodalton tyrosine-phosphorylated protein induced by interleukin-11 as JAK2 tyrosine kinase, which associates with gp130 signal transducer
18. Interleukin (IL)-11 mediated signal transduction
19. Constitutive activation of Stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells
20. STAT-related transcription factors are constitutively activated in peripheral blood cells from acute leukemia patients
21. Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines
22. Constitutive activation of JAKs and STATs in BCR-Abl-expressing cell lines and peripheral blood cells derived from leukemic patients
23. Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor-mediated cell growth in vitro
24. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells
25. Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein
26. Stat3 activation is required for cellular transformation by v-src
27. Stat3 as an oncogene
28. Gene therapy with dominant negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo
29. rsk activation in signalling pathways shared by interleukin-11, interleukin-6, leukemia inhibitory factor and oncostatin M in mouse 3T3 L1 cells
30. Activation of src-family protein tyrosine kinases and phosphatidyl-inositol-3-kinase in 3T3 mouse preadipocytes by interleukin-11
31. Complex formation of JAK2 with PP2A, PI3K, and yes in response to the hematopoietic cytokine interleukin-11
32. Interleukin-6: A candidate mediator of human prostate cancer morbidity
33. Interleukin-6 induces prostate cancer cell growth accompanied by activation of Stat3 signaling pathway
34. Expression of multiple angiogenic cytokines in cultured normal human prostate epithelial cells: Predominance of vascular endothelial growth factor
35. Expression and function of colony stimulating factors and their receptors in human prostate carcinoma cell lines
36. Transcription factor p91 interacts with the epidermal growth factor receptor and mediates activation of the c-fos gene promoter
37. Expression and function of members of the cytokine receptor superfamily on breast cancer cells
38. Expression of transcripts of interleukin-6 and related cytokines by human breast tumors, breast cancer cells, and adipose stromal cells
39. Production and regulation of interleukin-11 by breast cancer cells
40. Coexpression of IL-11 and IL-11 receptor in primary neoplasms (ovarian) and cultured cell lines
41. Interleukin 6 activates androgen receptor-mediated gene expression through a signal transducer and activator of transcription 3-dependent pathway in LNCaP prostate cancer cells
42. Inhibition of constitutively activated Stat3 signaling pathway suppresses growth of prostate cancer cells